iPSC-based disease modeling

Leveraging iPSCs for advanced disease modeling in drug discovery.

by Evotec · Drug Discovery AI

Executive Summary

Evotec's iPSC-based disease modeling platform offers a cutting-edge solution for drug discovery and development by leveraging induced Pluripotent Stem Cells. This platform enables the creation of highly relevant human disease models in vitro, providing a powerful tool for understanding disease pathophysiology, identifying novel therapeutic targets, and screening potential drug candidates. By mimicking human disease conditions more accurately than traditional models, the platform aims to accelerate the discovery of effective and safer treatments. The platform is designed with flexibility in mind, offering tailored partnering models to integrate seamlessly into the diverse research pipelines of pharmaceutical and biotech companies. Evotec's integrated approach, potentially enhanced by AI-driven methodologies, supports comprehensive data generation and analysis, facilitating informed decision-making throughout the preclinical development process. This commitment to advanced modeling and integrated solutions underscores Evotec's role in de-risking and expediting drug development.

Use Cases

  • Developing human-relevant in vitro disease models
  • Identifying and validating novel drug targets
  • High-throughput screening of therapeutic compounds
  • Investigating disease mechanisms and pathways
  • Assessing drug efficacy and toxicity in a human context

Features

Visibility

  • Data Visualization: Interactive visualization of complex biological data generated from iPSC models.
  • Project Tracking: Monitoring of experimental progress and key milestones within the disease modeling projects.

Intelligence

  • Predictive Modeling: Utilizing AI and computational methods to predict drug efficacy and toxicity in iPSC models.
  • Target Prioritization: Identifying and prioritizing novel drug targets based on insights from disease models.

Technical Specifications

API Available
Yes

Pricing

Model
Service-based, custom engagement
Starting Price
Contact sales
Target Customer
Enterprise
Contract Type
Custom, project-based
Free Trial
No

About Evotec

Evotec is a life science company pioneering drug discovery and development by integrating breakthrough science with AI-driven innovation and advanced technologies. They accelerate the journey from concept to cure, offering drug discovery alliance and development services for the biopharma sector. Evotec partners with pharmaceutical and biotechnology companies, academic institutions, and other healthcare stakeholders globally.

Founded: 1993 · Headquarters: Hamburg, Germany · Employees: 1000+ · Public